Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Davis

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Immunology|September 21, 2020
Inhibition of the NLRP3 inflammasome by HSP90 inhibitorsSohaib Nizami, Kanisa Arunasalam, Jack Green, et al.
Carcinogenesis|August 5, 2020
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cellsLarisa M Gearhart-Serna, John B Davis, Mohit Kumar Jolly, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
Experimental Neurology|March 26, 2009
Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM miceJennifer C Roberts, Sarah L Friel, Shilina Roman, et al.
Scientific Reports|July 29, 2021
A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activationSohaib Nizami, Val Millar, Kanisa Arunasalam, et al.
Scientific Reports|October 12, 2021
Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activationSohaib Nizami, Val Millar, Kanisa Arunasalam, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 7, 2003
Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h)Alison M Ray, Ceri D Benham, Jenny C Roberts, et al.
The Journal of Biological Chemistry|January 24, 2002
Cloning and functional expression of human short TRP7, a candidate protein for store-operated Ca2+ influxAntonio Riccio, Cesar Mattei, Rosemary E Kelsell, et al.
Life Sciences|November 9, 2010
Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cellsJohn P M White, Guy Calcott, Agnes Jenes, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Discovery of small molecule antagonists of TRPV1Harshad K Rami, Mervyn Thompson, Paul Wyman, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Immunology|September 21, 2020
Inhibition of the NLRP3 inflammasome by HSP90 inhibitorsSohaib Nizami, Kanisa Arunasalam, Jack Green, et al.
Carcinogenesis|August 5, 2020
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cellsLarisa M Gearhart-Serna, John B Davis, Mohit Kumar Jolly, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
Experimental Neurology|March 26, 2009
Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM miceJennifer C Roberts, Sarah L Friel, Shilina Roman, et al.
Scientific Reports|July 29, 2021
A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activationSohaib Nizami, Val Millar, Kanisa Arunasalam, et al.
Scientific Reports|October 12, 2021
Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activationSohaib Nizami, Val Millar, Kanisa Arunasalam, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 7, 2003
Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h)Alison M Ray, Ceri D Benham, Jenny C Roberts, et al.
The Journal of Biological Chemistry|January 24, 2002
Cloning and functional expression of human short TRP7, a candidate protein for store-operated Ca2+ influxAntonio Riccio, Cesar Mattei, Rosemary E Kelsell, et al.
Life Sciences|November 9, 2010
Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cellsJohn P M White, Guy Calcott, Agnes Jenes, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Discovery of small molecule antagonists of TRPV1Harshad K Rami, Mervyn Thompson, Paul Wyman, et al.
Pageof 6